RecruitingNCT06830590
Study of Molecular Characterisation of Early Operable Primary Breast Cancer in Pakistani Population
Sponsor
Liaquat University of Medical & Health Sciences
Enrollment
300 participants
Start Date
Feb 1, 2016
Study Type
OBSERVATIONAL
Conditions
Summary
This study is looking at the biological characteristics of early operable primary breast cancer in Pakistani Population by using IHC
Eligibility
Sex: FEMALE
Plain Language Summary
Simplified for easier understanding
This study is examining the biological characteristics of early-stage breast cancer in Pakistani women. Researchers will analyze tumor samples to understand how breast cancer behaves differently in this population, which could improve how it is diagnosed and treated locally.
**You may be eligible if...**
- You are a woman with a confirmed breast cancer diagnosis
- Your cancer has not been treated with chemotherapy or other systemic therapy before surgery
- A good quality tumor tissue sample is available for laboratory analysis
**You may NOT be eligible if...**
- You have already received chemotherapy or radiation therapy before surgery (called neoadjuvant treatment)
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDUREMolecular characterisation
All patients treated by surgery were included without any neoadjuvant therapy
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06830590
Related Trials
Genomic Services Research Program
NCT025959571 location
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
NCT052833304 locations
A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)
NCT070671381 location
Social and Environmental Determinants of Breast Cancer Survivorship: the Black Breast Cancer Survivor's Intervention (BBCSI)
NCT068852031 location
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer
NCT06103864316 locations